Ori Melamud, MD
Urology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Melamud’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A84986 · Current
Licensed to practise in California · since 2003 · expires 2027-08-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$319,917
Medicare paid this office $319,917 for 881 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 529 | $87,799 | $105 |
| Diagnostic exam of bladder and urethra using an endoscope | 114 | $38,390 | $243 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 35 | $32,877 | None |
| Short return visit (20+ min) | 277 | $24,528 | $73 |
| New patient visit (45+ min) | 155 | $22,312 | $144 |
See all 25 services
| Return visit (30+ min) | 529 | $87,799 | $105 |
| Diagnostic exam of bladder and urethra using an endoscope | 114 | $38,390 | $243 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 35 | $32,877 | None |
| Short return visit (20+ min) | 277 | $24,528 | $73 |
| New patient visit (45+ min) | 155 | $22,312 | $144 |
| Insertion of needle or tube into prostate for radiation therapy | 23 | $16,384 | $712 |
| Insertion of lower leg neurostimulator electrode | 13 | $8,309 | $120 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 454 | $7,931 | $14 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 18 | $7,200 | $360 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 18 | $5,816 | $323 |
| Ultrasound scan of pelvic region through rectum | 36 | $5,261 | $146 |
| Simple insertion of temporary bladder tube | 17 | $3,618 | $59 |
| Biopsy of prostate gland | 15 | $3,465 | $231 |
| Ultrasound measurement of bladder capacity after voiding | 193 | $2,934 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,809 | $69 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 35 | $2,235 | $37 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,837 | $115 |
| Ultrasonic guidance for administration of radiation therapy | 23 | $1,412 | $61 |
| Simple bladder irrigation and/or instillation | 12 | $1,253 | $78 |
| Automated urinalysis test | 324 | $888 | $2 |
| Injection of drug or substance under skin or into muscle | 35 | $742 | $13 |
| Manual urinalysis test with examination using microscope, automated | 203 | $740 | $3 |
| Imaging of urinary tract following injection of a contrast agent | 22 | $587 | $21 |
| Injection procedure for imaging of bladder during voiding | 23 | $433 | $19 |
| Injection, garamycin, gentamicin, up to 80 mg | 37 | $70 | None |
Procedures Medicare counted
| Prostate resection | 11 | More than 58% of doctors who do this |
Who their Medicare patients are
881 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 17% · Women 21% · Also on Medicaid 5% · Health risk score 1.10. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 73% · Cancer 30% · Diabetes 29% · Coronary heart disease 27% · Chronic kidney disease 25% · Atrial fibrillation 22% · Heart failure 14% · Depression 12% · COPD 11% · Dementia 6% · Stroke 5%.
The office billed $1,528,456, Medicare allowed $431,978 and paid $319,917; for 11,615 services of 75 kinds; $40,091 of it was for drugs given in the office and $279,826 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 881 | 11,615 | 77 | 1.10 | $1,528,456 | $319,917 |
| 2023 | 825 | 6,445 | 77 | 1.08 | $1,323,583 | $272,175 |
| 2022 | 861 | 5,312 | 76 | 1.15 | $1,330,828 | $284,867 |
| 2021 | 869 | 4,462 | 77 | 1.18 | $1,192,074 | $268,572 |
| 2020 | 768 | 6,099 | 76 | 1.19 | $1,078,170 | $223,205 |
| 2019 | 815 | 3,578 | 77 | 1.28 | $1,376,583 | $257,584 |
| 2018 | 826 | 3,131 | 76 | 1.24 | $1,118,487 | $236,010 |
| 2017 | 617 | 2,841 | 75 | 1.28 | $655,038 | $201,216 |
| 2016 | 517 | 2,379 | 75 | 1.36 | $607,995 | $191,040 |
| 2015 | 511 | 2,570 | 76 | 1.39 | $552,727 | $180,313 |
| 2014 | 396 | 2,261 | 76 | 1.31 | $412,199 | $154,636 |
| 2013 | 364 | 4,195 | 76 | 1.33 | $332,063 | $153,938 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Return visit (30+ min) | 393 | $62,323 | $109 |
| Short return visit (20+ min) | 396 | $36,869 | $73 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 34 | $33,786 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 105 | $33,637 | $235 |
| New patient visit (45+ min) | 125 | $17,365 | $139 |
| Insertion of needle or tube into prostate for radiation therapy | 23 | $16,520 | $718 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 17 | $5,537 | $326 |
| Biopsy of prostate gland | 20 | $4,645 | $232 |
| Simple insertion of temporary bladder tube | 11 | $4,049 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $3,374 | $72 |
| Ultrasound measurement of bladder capacity after voiding | 189 | $2,633 | $11 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,397 | $114 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 34 | $2,286 | $36 |
| New patient visit (30+ min) | 20 | $1,842 | $92 |
| Insertion of stent in ureter using an endoscope | 14 | $1,557 | $104 |
| Ultrasonic guidance for administration of radiation therapy | 23 | $1,433 | $62 |
| Ultrasonic guidance for needle placement | 11 | $643 | $58 |
| Imaging of urinary tract following injection of a contrast agent | 21 | $557 | $22 |
| Automated urinalysis test | 208 | $510 | $2 |
| Manual urinalysis test with examination using microscope, automated | 138 | $488 | $3 |
| Injection procedure for imaging of bladder during voiding | 23 | $445 | $19 |
| Injection of drug or substance under skin or into muscle | 15 | $366 | $13 |
| Injection, tobramycin sulfate, up to 80 mg | 14 | $28 | None |
2022: 25 services
| Return visit (30+ min) | 328 | $47,853 | $105 |
| Short return visit (20+ min) | 454 | $44,044 | $72 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 37 | $43,779 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 98 | $32,217 | $242 |
| New patient visit (45+ min) | 131 | $17,578 | $134 |
| Insertion of needle or tube into prostate for radiation therapy | 21 | $14,877 | $708 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $6,303 | $371 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 18 | $6,179 | $325 |
| Simple insertion of temporary bladder tube | 14 | $4,895 | $56 |
| Biopsy of prostate gland | 17 | $4,118 | $242 |
| New patient visit (30+ min) | 39 | $3,605 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $3,238 | $63 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 37 | $2,741 | $34 |
| Ultrasound measurement of bladder capacity after voiding | 176 | $2,379 | $10 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,051 | $114 |
| Simple bladder irrigation and/or instillation | 18 | $1,701 | $77 |
| Ultrasonic guidance for administration of radiation therapy | 21 | $1,292 | $62 |
| Ultrasonic guidance for needle placement | 16 | $923 | $58 |
| Imaging of urinary tract following injection of a contrast agent | 21 | $559 | $22 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $473 | $36 |
| Injection of drug or substance under skin or into muscle | 19 | $422 | $14 |
| Injection procedure for imaging of bladder during voiding | 21 | $408 | $19 |
| Manual urinalysis test with examination using microscope, automated | 87 | $323 | $3 |
| Automated urinalysis test | 80 | $224 | $2 |
| Injection, garamycin, gentamicin, up to 80 mg | 12 | $17 | None |
2021: 24 services
| Return visit (30+ min) | 320 | $49,248 | $115 |
| Short return visit (20+ min) | 471 | $45,604 | $72 |
| Diagnostic exam of bladder and urethra using an endoscope | 99 | $31,459 | $238 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 29 | $27,699 | None |
| New patient visit (45+ min) | 135 | $19,965 | $148 |
| Insertion of needle or tube into prostate for radiation therapy | 13 | $9,293 | $715 |
| Simple insertion of temporary bladder tube | 19 | $6,028 | $59 |
| Biopsy of prostate gland | 24 | $5,785 | $241 |
| New patient visit (30+ min) | 68 | $5,539 | $81 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 16 | $5,067 | $317 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 11 | $4,835 | $372 |
| Ultrasound measurement of bladder capacity after voiding | 205 | $2,675 | $10 |
| Simple bladder irrigation and/or instillation | 21 | $2,417 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,961 | $115 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 29 | $1,791 | $34 |
| Ultrasonic guidance for needle placement | 21 | $1,206 | $57 |
| Telephone medical discussion with physician, 5-10 minutes | 22 | $1,078 | $41 |
| Ultrasonic guidance for administration of radiation therapy | 13 | $810 | $62 |
| Injection of drug or substance under skin or into muscle | 26 | $571 | $13 |
| Manual urinalysis test with examination using microscope, automated | 148 | $510 | $3 |
| Automated urinalysis test | 171 | $441 | $2 |
| Imaging of urinary tract following injection of a contrast agent | 17 | $411 | $23 |
| Injection procedure for imaging of bladder during voiding | 13 | $257 | $20 |
| Injection, garamycin, gentamicin, up to 80 mg | 24 | $35 | None |
2020: 24 services
| Short return visit (20+ min) | 523 | $47,388 | $60 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 23 | $35,346 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 90 | $23,466 | $204 |
| New patient visit (30+ min) | 132 | $11,880 | $90 |
| New patient visit (45+ min) | 79 | $10,685 | $135 |
| Return visit (30+ min) | 83 | $9,807 | $100 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $7,289 | $663 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 18 | $6,744 | $375 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 19 | $5,452 | $287 |
| Simple insertion of temporary bladder tube | 23 | $5,065 | $58 |
| Biopsy of prostate gland | 14 | $3,417 | $244 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,958 | $66 |
| Ultrasound measurement of bladder capacity after voiding | 183 | $2,588 | $10 |
| Simple bladder irrigation and/or instillation | 20 | $2,208 | $74 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 23 | $1,757 | $33 |
| Insertion of stent in ureter using an endoscope | 12 | $1,444 | $120 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,387 | $107 |
| Telephone medical discussion with physician, 5-10 minutes | 27 | $1,167 | $43 |
| Ultrasonic guidance for needle placement | 14 | $796 | $57 |
| Automated urinalysis test | 265 | $714 | $2 |
| Imaging of urinary tract following injection of a contrast agent | 26 | $709 | $24 |
| Manual urinalysis test with examination using microscope, automated | 164 | $588 | $3 |
| Injection of drug or substance under skin or into muscle | 19 | $420 | $12 |
| Injection, garamycin, gentamicin, up to 80 mg | 15 | $22 | None |
2019: 25 services
| Short return visit (20+ min) | 638 | $60,699 | $59 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 34 | $47,084 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 106 | $25,541 | $175 |
| New patient visit (45+ min) | 135 | $18,495 | $137 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 14 | $9,045 | $646 |
| Insertion of needle or tube into prostate for radiation therapy | 12 | $8,389 | $699 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 17 | $6,720 | $373 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 21 | $6,152 | $256 |
| Return visit (30+ min) | 42 | $4,563 | $99 |
| Simple insertion of temporary bladder tube | 16 | $4,395 | $58 |
| Biopsy of prostate gland | 16 | $3,465 | $217 |
| New patient visit (30+ min) | 40 | $3,126 | $78 |
| Ultrasound measurement of bladder capacity after voiding | 172 | $2,963 | $12 |
| Simple bladder irrigation and/or instillation | 23 | $2,826 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,125 | $64 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 34 | $2,028 | $31 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,931 | $121 |
| Manual urinalysis test with examination using microscope, automated | 217 | $933 | $3 |
| Ultrasonic guidance for needle placement | 15 | $818 | $55 |
| Ultrasonic guidance for administration of radiation therapy | 12 | $734 | $61 |
| Automated urinalysis test | 168 | $543 | $2 |
| Imaging of urinary tract following injection of a contrast agent | 19 | $509 | $23 |
| Injection of drug or substance under skin or into muscle | 19 | $307 | $16 |
| Injection procedure for imaging of bladder during voiding | 12 | $239 | $20 |
| Injection, garamycin, gentamicin, up to 80 mg | 16 | $22 | None |
2018: 26 services
| Short return visit (20+ min) | 626 | $60,845 | $58 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 34 | $38,818 | None |
| New patient visit (45+ min) | 179 | $24,671 | $138 |
| Diagnostic exam of bladder and urethra using an endoscope | 116 | $22,257 | $151 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 12 | $7,711 | $643 |
| Insertion of needle or tube into prostate for radiation therapy | 11 | $7,476 | $680 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 11 | $3,829 | $348 |
| New patient visit (30+ min) | 39 | $3,455 | $89 |
| Return visit (30+ min) | 34 | $3,290 | $94 |
| Biopsy of prostate gland | 15 | $3,147 | $210 |
| Simple insertion of temporary bladder tube | 12 | $3,106 | $63 |
| Ultrasound measurement of bladder capacity after voiding | 154 | $3,073 | $16 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 12 | $2,822 | $235 |
| Simple bladder irrigation and/or instillation | 22 | $2,430 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,407 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,917 | $174 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 35 | $1,848 | $31 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,523 | $117 |
| Complete ultrasound scan of pelvis | 11 | $1,149 | $104 |
| Automated urinalysis test | 291 | $994 | $3 |
| Ultrasonic guidance for needle placement | 14 | $810 | $58 |
| Manual urinalysis test with examination using microscope, automated | 141 | $635 | $4 |
| Injection of drug or substance under skin or into muscle | 13 | $283 | $20 |
| Imaging of urinary tract following injection of a contrast agent | 16 | $254 | $16 |
| Urinalysis, manual test | 12 | $41 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 16 | $19 | None |
2017: 17 services
| Short return visit (20+ min) | 468 | $54,179 | $60 |
| New patient visit (45+ min) | 235 | $31,965 | $136 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 27 | $30,337 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 65 | $16,637 | $157 |
| Complete ultrasound scan of pelvis | 81 | $10,554 | $110 |
| Biopsy of prostate gland | 24 | $5,578 | $232 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,427 | $180 |
| Manual urinalysis test with examination using microscope, non-automated | 484 | $3,409 | $4 |
| Ultrasound scan of pelvic region through rectum | 24 | $2,314 | $96 |
| Simple bladder irrigation and/or instillation | 25 | $2,212 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,933 | $64 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 27 | $1,615 | $33 |
| Ultrasonic guidance for needle placement | 23 | $1,351 | $59 |
| Ultrasound measurement of bladder capacity after voiding | 33 | $651 | $20 |
| Imaging of urinary tract following injection of a contrast agent | 11 | $192 | $16 |
| Automated urinalysis test | 57 | $170 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 24 | $29 | None |
2016: 15 services
| Short return visit (20+ min) | 388 | $44,458 | $62 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 16 | $23,215 | None |
| New patient visit (45+ min) | 172 | $23,015 | $134 |
| Diagnostic exam of bladder and urethra using an endoscope | 62 | $17,986 | $198 |
| Complete ultrasound scan of pelvis | 77 | $10,764 | $111 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 14 | $10,685 | $763 |
| Biopsy of prostate gland | 21 | $4,048 | $193 |
| Manual urinalysis test with examination using microscope, non-automated | 431 | $3,140 | $4 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,345 | $180 |
| Simple bladder irrigation and/or instillation | 19 | $1,963 | $79 |
| Ultrasound scan of pelvic region through rectum | 21 | $1,948 | $93 |
| Ultrasonic guidance for needle placement | 20 | $1,173 | $59 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 16 | $1,120 | $33 |
| Return visit (30+ min) | 11 | $1,114 | $93 |
| Injection, garamycin, gentamicin, up to 80 mg | 20 | $22 | None |
2015: 16 services
| Short return visit (20+ min) | 357 | $43,483 | $63 |
| New patient visit (45+ min) | 192 | $26,473 | $138 |
| Diagnostic exam of bladder and urethra using an endoscope | 64 | $15,811 | $186 |
| Complete ultrasound scan of pelvis | 103 | $14,997 | $107 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 11 | $13,132 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,789 | $180 |
| Simple bladder irrigation and/or instillation | 24 | $3,000 | $81 |
| Manual urinalysis test with examination using microscope, non-automated | 415 | $2,933 | $4 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,317 | $122 |
| Biopsy of prostate gland | 11 | $2,213 | $201 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,138 | $65 |
| Ultrasound scan of pelvic region through rectum | 11 | $1,050 | $95 |
| Ultrasonic guidance for needle placement | 11 | $647 | $59 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 12 | $599 | $30 |
| Ultrasound measurement of bladder capacity after voiding | 12 | $262 | $17 |
| Injection, garamycin, gentamicin, up to 80 mg | 12 | $14 | None |
2014: 20 services
| Short return visit (20+ min) | 258 | $28,426 | $62 |
| New patient visit (45+ min) | 179 | $25,298 | $141 |
| Diagnostic exam of bladder and urethra using an endoscope | 51 | $13,550 | $191 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 12 | $12,605 | None |
| Complete ultrasound scan of pelvis | 74 | $11,616 | $126 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 12 | $4,991 | $357 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 12 | $2,983 | $229 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,564 | $64 |
| Manual urinalysis test with examination using microscope, non-automated | 329 | $2,272 | $4 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,160 | $180 |
| Biopsy of prostate gland | 11 | $2,155 | $196 |
| Return visit (30+ min) | 18 | $1,774 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,584 | $122 |
| Insertion of stent in ureter using an endoscope | 12 | $1,392 | $116 |
| Simple bladder irrigation and/or instillation | 12 | $1,149 | $77 |
| Ultrasound scan of pelvic region through rectum | 11 | $1,028 | $93 |
| Ultrasonic guidance for needle placement | 11 | $798 | $73 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 13 | $710 | $32 |
| Imaging of urinary tract following injection of a contrast agent | 18 | $341 | $16 |
| Injection, garamycin, gentamicin, up to 80 mg | 12 | $14 | None |
2013: 15 services
| Short return visit (20+ min) | 235 | $25,945 | $60 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 13 | $16,008 | None |
| New patient visit (45+ min) | 97 | $14,248 | $147 |
| Complete ultrasound scan of pelvis | 64 | $10,941 | $124 |
| Diagnostic exam of bladder and urethra using an endoscope | 32 | $9,238 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $4,833 | $63 |
| Return visit (30+ min) | 44 | $3,919 | $85 |
| Ultrasonic guidance for needle placement | 16 | $3,475 | $217 |
| Biopsy of prostate gland | 16 | $3,301 | $206 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,100 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,274 | $175 |
| Manual urinalysis test with examination using microscope, non-automated | 292 | $2,146 | $4 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $1,227 | $33 |
| Ultrasound scan of pelvic region through rectum | 16 | $1,158 | $72 |
| Injection, garamycin, gentamicin, up to 80 mg | 19 | $19 | None |
Medicaid work
$259 in 2024
Medicaid paid $259 for 13 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $259 |
| 2024 | 13 | 1 | 13 | $259 |
| 2022 | 15 | 1 | 15 | $0 |
| 2021 | 27 | 1 | 13 | $340 |
| 2020 | 71 | 1 | 18 | $534 |
| 2019 | 160 | 1 | 25 | $1,324 |
| 2018 | 245 | 2 | 25 | $2,259 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 15 | $0 |
2021
| Short return visit (20+ min) | 27 | $340 |
2020
| Short return visit (20+ min) | 71 | $534 |
2019
| Short return visit (20+ min) | 160 | $1,324 |
2018
| Short return visit (20+ min) | 229 | $2,242 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 16 | $17 |
Drugs they prescribed that Part D paid
$397,591
Pharmacies billed $397,591 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
5,959 generic and 281 brand-name prescriptions · $397,591 in drug cost · 767 antibiotic prescriptions to 305 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 199 | $168,027 | $844 |
| Tamsulosin | 1,950 | $45,209 | $23 |
| Finasteride | 1,659 | $29,145 | $18 |
| Potassium Citrate Er | 121 | $20,047 | $166 |
| Elmiron | 12 | $19,138 | $1,595 |
See all 35 drugs
| Myrbetriq | 199 | $168,027 | $844 |
| Tamsulosin | 1,950 | $45,209 | $23 |
| Finasteride | 1,659 | $29,145 | $18 |
| Potassium Citrate Er | 121 | $20,047 | $166 |
| Elmiron | 12 | $19,138 | $1,595 |
| Gemtesa | 21 | $18,614 | $886 |
| Oxybutynin Chloride Er | 361 | $12,508 | $35 |
| Solifenacin | 107 | $8,845 | $83 |
| Methenamine Hippurate | 58 | $6,640 | $114 |
| Fesoterodine Fumarate Er | 14 | $5,880 | $420 |
| Estradiol | 72 | $5,294 | $74 |
| Silodosin | 55 | $5,273 | $96 |
| Testosterone | 40 | $3,718 | $93 |
| Alfuzosin Hcl Er | 136 | $3,414 | $25 |
| Dutasteride | 50 | $3,372 | $67 |
| Tolterodine Tartrate Er | 24 | $3,136 | $131 |
| Cephalexin | 349 | $3,085 | $9 |
| Nitrofurantoin Mono-Macro | 91 | $2,795 | $31 |
| Desmopressin Acetate | 31 | $1,959 | $63 |
| Tadalafil | 40 | $1,954 | $49 |
| Oxybutynin Chloride | 121 | $1,779 | $15 |
| Yuvafem | 17 | $1,740 | $102 |
| Doxazosin Mesylate | 61 | $1,111 | $18 |
| Terazosin | 34 | $1,041 | $31 |
| Testosterone Cypionate | 24 | $788 | $33 |
| Bicalutamide | 25 | $774 | $31 |
| Allopurinol | 70 | $644 | $9 |
| Nitrofurantoin | 34 | $586 | $17 |
| Clotrimazole-Betamethasone | 48 | $553 | $12 |
| Sulfamethoxazole-Trimethoprim | 94 | $383 | $4 |
| Ciprofloxacin | 93 | $354 | $4 |
| Amoxicillin-Clavulanate Potass | 24 | $324 | $14 |
| Levofloxacin | 58 | $139 | $2 |
| Hydrochlorothiazide | 18 | $63 | $4 |
| Lorazepam | 13 | $7 | $1 |
Year by year
| 2024 | 6,240 | 1,196 | None | 5% | $397,591 |
| 2023 | 5,954 | 1,110 | None | None | $439,543 |
| 2022 | 5,834 | 1,077 | None | 6% | $446,928 |
| 2021 | 5,642 | 1,040 | 0% (22) | None | $542,547 |
| 2020 | 5,449 | 971 | 1% (34) | None | $516,516 |
| 2019 | 5,525 | 1,015 | 1% (58) | None | $519,100 |
| 2018 | 5,593 | 970 | 1% (64) | None | $548,017 |
| 2017 | 4,770 | 771 | 1% (58) | 14% | $420,411 |
| 2016 | 4,512 | 659 | 2% (67) | 16% | $366,783 |
| 2015 | 3,941 | 572 | 1% (38) | None | $394,318 |
| 2014 | 2,898 | 425 | 2% (44) | None | $180,192 |
| 2013 | 2,110 | 322 | 2% (44) | None | $143,682 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Myrbetriq | 248 | $204,260 | $824 |
| Tamsulosin | 1,942 | $59,803 | $31 |
| Finasteride | 1,645 | $34,129 | $21 |
| Potassium Citrate Er | 119 | $22,676 | $191 |
| Oxybutynin Chloride Er | 321 | $14,458 | $45 |
| Solifenacin | 104 | $8,913 | $86 |
| Fesoterodine Fumarate Er | 11 | $7,798 | $709 |
| Rapaflo | 17 | $7,088 | $417 |
| Silodosin | 40 | $6,587 | $165 |
| Testosterone | 37 | $5,513 | $149 |
| Estradiol | 49 | $5,408 | $110 |
| Tolterodine Tartrate Er | 25 | $4,955 | $198 |
| Alfuzosin Hcl Er | 108 | $4,108 | $38 |
| Dutasteride | 65 | $4,016 | $62 |
| Methenamine Hippurate | 47 | $3,910 | $83 |
| Nitrofurantoin Mono-Macro | 63 | $3,579 | $57 |
| Cephalexin | 266 | $2,228 | $8 |
| Desmopressin Acetate | 42 | $2,150 | $51 |
| Trospium Chloride | 13 | $2,050 | $158 |
| Doxazosin Mesylate | 63 | $1,821 | $29 |
| Oxybutynin Chloride | 97 | $1,767 | $18 |
| Tadalafil | 29 | $1,530 | $53 |
| Bicalutamide | 19 | $1,454 | $77 |
| Terazosin | 42 | $1,105 | $26 |
| Cefpodoxime Proxetil | 21 | $1,035 | $49 |
| Testosterone Cypionate | 33 | $979 | $30 |
| Allopurinol | 47 | $797 | $17 |
| Nitrofurantoin | 26 | $742 | $29 |
| Ciprofloxacin | 107 | $592 | $6 |
| Clotrimazole-Betamethasone | 32 | $467 | $15 |
| Amoxicillin-Clavulanate Potass | 34 | $415 | $12 |
| Sulfamethoxazole-Trimethoprim | 72 | $384 | $5 |
| Levofloxacin | 48 | $161 | $3 |
2022: 33 drugs
| Myrbetriq | 253 | $202,540 | $801 |
| Tamsulosin | 1,957 | $56,459 | $29 |
| Finasteride | 1,718 | $40,582 | $24 |
| Potassium Citrate Er | 69 | $16,773 | $243 |
| Toviaz | 21 | $16,090 | $766 |
| Oxybutynin Chloride Er | 304 | $14,637 | $48 |
| Solifenacin | 131 | $9,798 | $75 |
| Rapaflo | 17 | $6,900 | $406 |
| Testosterone | 36 | $5,919 | $164 |
| Silodosin | 51 | $5,768 | $113 |
| Dutasteride | 55 | $4,364 | $79 |
| Tolterodine Tartrate Er | 24 | $4,306 | $179 |
| Estradiol | 44 | $4,196 | $95 |
| Desmopressin Acetate | 55 | $2,741 | $50 |
| Alfuzosin Hcl Er | 81 | $2,699 | $33 |
| Doxazosin Mesylate | 67 | $2,558 | $38 |
| Oxybutynin Chloride | 101 | $2,303 | $23 |
| Acyclovir | 16 | $2,207 | $138 |
| Cephalexin | 234 | $1,856 | $8 |
| Nitrofurantoin | 47 | $1,599 | $34 |
| Terazosin | 44 | $1,275 | $29 |
| Trospium Chloride | 12 | $1,195 | $100 |
| Methenamine Hippurate | 12 | $1,116 | $93 |
| Testosterone Cypionate | 24 | $815 | $34 |
| Tadalafil | 21 | $784 | $37 |
| Bicalutamide | 22 | $757 | $34 |
| Ciprofloxacin | 105 | $607 | $6 |
| Nitrofurantoin Mono-Macro | 23 | $513 | $22 |
| Allopurinol | 27 | $468 | $17 |
| Amoxicillin-Clavulanate Potass | 26 | $417 | $16 |
| Clotrimazole-Betamethasone | 19 | $296 | $16 |
| Sulfamethoxazole-Trimethoprim | 53 | $237 | $4 |
| Levofloxacin | 48 | $157 | $3 |
2021: 32 drugs
| Myrbetriq | 311 | $228,017 | $733 |
| Finasteride | 1,704 | $47,931 | $28 |
| Tamsulosin | 1,873 | $46,485 | $25 |
| Toviaz | 28 | $19,767 | $706 |
| Potassium Citrate Er | 81 | $16,681 | $206 |
| Oxybutynin Chloride Er | 332 | $15,990 | $48 |
| Solifenacin | 121 | $8,923 | $74 |
| Elmiron | 11 | $7,634 | $694 |
| Rapaflo | 17 | $6,972 | $410 |
| Testosterone | 40 | $6,773 | $169 |
| Silodosin | 57 | $6,473 | $114 |
| Acyclovir | 14 | $4,255 | $304 |
| Dutasteride | 58 | $3,764 | $65 |
| Estradiol | 34 | $3,586 | $105 |
| Tolterodine Tartrate Er | 17 | $3,533 | $208 |
| Alfuzosin Hcl Er | 73 | $3,064 | $42 |
| Nitrofurantoin | 52 | $2,119 | $41 |
| Oxybutynin Chloride | 68 | $2,031 | $30 |
| Doxazosin Mesylate | 61 | $1,955 | $32 |
| Terazosin | 52 | $1,767 | $34 |
| Cephalexin | 216 | $1,207 | $6 |
| Desmopressin Acetate | 24 | $1,129 | $47 |
| Bicalutamide | 16 | $779 | $49 |
| Tadalafil | 11 | $754 | $69 |
| Clotrimazole-Betamethasone | 23 | $490 | $21 |
| Amoxicillin-Clavulanate Potass | 22 | $416 | $19 |
| Allopurinol | 20 | $349 | $17 |
| Nitrofurantoin Mono-Macro | 13 | $317 | $24 |
| Ciprofloxacin | 74 | $261 | $4 |
| Sulfamethoxazole-Trimethoprim | 51 | $217 | $4 |
| Levofloxacin | 44 | $113 | $3 |
| Oxycodone-Acetaminophen | 12 | $39 | $3 |
2020: 31 drugs
| Myrbetriq | 305 | $210,496 | $690 |
| Tamsulosin | 1,788 | $49,403 | $28 |
| Finasteride | 1,646 | $45,790 | $28 |
| Potassium Citrate Er | 96 | $22,239 | $232 |
| Toviaz | 37 | $20,830 | $563 |
| Oxybutynin Chloride Er | 255 | $14,329 | $56 |
| Elmiron | 12 | $11,575 | $965 |
| Solifenacin | 105 | $10,504 | $100 |
| Testosterone | 40 | $10,168 | $254 |
| Silodosin | 70 | $9,178 | $131 |
| Estradiol | 43 | $8,310 | $193 |
| Rapaflo | 19 | $7,993 | $421 |
| Dutasteride | 72 | $4,842 | $67 |
| Acyclovir | 12 | $4,283 | $357 |
| Tadalafil | 15 | $4,050 | $270 |
| Tolterodine Tartrate Er | 25 | $3,907 | $156 |
| Terazosin | 52 | $2,386 | $46 |
| Doxazosin Mesylate | 68 | $2,265 | $33 |
| Alfuzosin Hcl Er | 56 | $2,215 | $40 |
| Oxybutynin Chloride | 74 | $2,152 | $29 |
| Cephalexin | 191 | $1,559 | $8 |
| Nitrofurantoin | 31 | $1,208 | $39 |
| Bicalutamide | 18 | $850 | $47 |
| Clotrimazole-Betamethasone | 19 | $757 | $40 |
| Doxycycline Hyclate | 16 | $586 | $37 |
| Ciprofloxacin | 114 | $540 | $5 |
| Sulfamethoxazole-Trimethoprim | 65 | $297 | $5 |
| Allopurinol | 20 | $266 | $13 |
| Levofloxacin | 28 | $210 | $8 |
| Hydrocodone-Acetaminophen | 28 | $168 | $6 |
| Amoxicillin-Clavulanate Potass | 12 | $121 | $10 |
2019: 31 drugs
| Myrbetriq | 259 | $159,517 | $616 |
| Vesicare | 71 | $59,587 | $839 |
| Tamsulosin | 1,852 | $50,337 | $27 |
| Finasteride | 1,642 | $45,352 | $28 |
| Elmiron | 25 | $24,974 | $999 |
| Toviaz | 35 | $18,344 | $524 |
| Potassium Citrate Er | 70 | $18,208 | $260 |
| Rapaflo | 39 | $16,566 | $425 |
| Oxybutynin Chloride Er | 293 | $15,645 | $53 |
| Solifenacin | 62 | $13,707 | $221 |
| Silodosin | 71 | $12,951 | $182 |
| Tadalafil | 18 | $5,398 | $300 |
| Estradiol | 26 | $5,246 | $202 |
| Acyclovir | 12 | $5,165 | $430 |
| Dutasteride | 71 | $4,612 | $65 |
| Testosterone | 14 | $4,471 | $319 |
| Nitrofurantoin | 43 | $3,010 | $70 |
| Tolterodine Tartrate Er | 31 | $2,463 | $79 |
| Oxybutynin Chloride | 82 | $2,240 | $27 |
| Terazosin | 51 | $2,238 | $44 |
| Cephalexin | 171 | $2,046 | $12 |
| Alfuzosin Hcl Er | 61 | $2,015 | $33 |
| Doxazosin Mesylate | 46 | $1,875 | $41 |
| Ciprofloxacin | 142 | $827 | $6 |
| Doxycycline Hyclate | 16 | $438 | $27 |
| Sulfamethoxazole-Trimethoprim | 59 | $386 | $7 |
| Clotrimazole-Betamethasone | 11 | $337 | $31 |
| Bicalutamide | 15 | $329 | $22 |
| Allopurinol | 14 | $223 | $16 |
| Hydrocodone-Acetaminophen | 50 | $200 | $4 |
| Levofloxacin | 35 | $171 | $5 |
2018: 27 drugs
| Myrbetriq | 224 | $126,642 | $565 |
| Vesicare | 170 | $96,857 | $570 |
| Tamsulosin | 1,773 | $55,669 | $31 |
| Rapaflo | 107 | $51,496 | $481 |
| Finasteride | 1,783 | $45,078 | $25 |
| Toviaz | 52 | $22,328 | $429 |
| Oxybutynin Chloride Er | 360 | $19,057 | $53 |
| Androgel | 22 | $18,181 | $826 |
| Elmiron | 20 | $14,826 | $741 |
| Cialis | 29 | $12,417 | $428 |
| Dutasteride | 96 | $9,567 | $100 |
| Zovirax | 11 | $8,776 | $798 |
| Potassium Citrate Er | 24 | $8,512 | $355 |
| Nitrofurantoin | 72 | $3,718 | $52 |
| Proscar | 11 | $1,990 | $181 |
| Oxybutynin Chloride | 73 | $1,907 | $26 |
| Alfuzosin Hcl Er | 44 | $1,694 | $38 |
| Cephalexin | 170 | $1,675 | $10 |
| Tolterodine Tartrate Er | 13 | $1,293 | $99 |
| Doxazosin Mesylate | 22 | $1,079 | $49 |
| Terazosin | 43 | $1,037 | $24 |
| Ciprofloxacin | 143 | $1,035 | $7 |
| Nitrofurantoin Mono-Macro | 17 | $568 | $33 |
| Sulfamethoxazole-Trimethoprim | 64 | $353 | $6 |
| Hydrocodone-Acetaminophen | 57 | $320 | $6 |
| Levofloxacin | 34 | $177 | $5 |
| Trimethoprim | 11 | $102 | $9 |
2017: 26 drugs
| Myrbetriq | 166 | $80,551 | $485 |
| Vesicare | 107 | $65,282 | $610 |
| Tamsulosin | 1,473 | $43,785 | $30 |
| Finasteride | 1,549 | $30,738 | $20 |
| Rapaflo | 101 | $29,935 | $296 |
| Cialis | 51 | $20,065 | $393 |
| Toviaz | 45 | $19,748 | $439 |
| Androgel | 29 | $18,449 | $636 |
| Oxybutynin Chloride Er | 362 | $17,769 | $49 |
| Potassium Citrate Er | 13 | $5,556 | $427 |
| Dutasteride | 47 | $4,233 | $90 |
| Nitrofurantoin | 58 | $2,942 | $51 |
| Nitrofurantoin Mono-Macro | 56 | $2,678 | $48 |
| Oxybutynin Chloride | 61 | $1,981 | $32 |
| Proscar | 12 | $1,883 | $157 |
| Tolterodine Tartrate Er | 12 | $1,543 | $129 |
| Alfuzosin Hcl Er | 21 | $1,136 | $54 |
| Ciprofloxacin | 142 | $1,108 | $8 |
| Methenamine Hippurate | 11 | $1,001 | $91 |
| Cephalexin | 137 | $981 | $7 |
| Doxazosin Mesylate | 28 | $815 | $29 |
| Levofloxacin | 24 | $327 | $14 |
| Terazosin | 19 | $316 | $17 |
| Cefuroxime | 12 | $316 | $26 |
| Sulfamethoxazole-Trimethoprim | 41 | $205 | $5 |
| Hydrocodone-Acetaminophen | 53 | $191 | $4 |
2016: 27 drugs
| Myrbetriq | 176 | $68,760 | $391 |
| Vesicare | 135 | $56,978 | $422 |
| Tamsulosin | 1,377 | $42,274 | $31 |
| Cialis | 68 | $23,210 | $341 |
| Finasteride | 1,318 | $22,165 | $17 |
| Rapaflo | 72 | $21,355 | $297 |
| Oxybutynin Chloride Er | 330 | $18,228 | $55 |
| Androgel | 27 | $13,484 | $499 |
| Toviaz | 39 | $12,611 | $323 |
| Dutasteride | 33 | $5,964 | $181 |
| Avodart | 11 | $5,110 | $465 |
| Nitrofurantoin Mono-Macro | 104 | $4,991 | $48 |
| Potassium Citrate Er | 25 | $4,423 | $177 |
| Tolterodine Tartrate Er | 19 | $3,307 | $174 |
| Methenamine Hippurate | 34 | $2,962 | $87 |
| Oxybutynin Chloride | 50 | $1,642 | $33 |
| Cephalexin | 143 | $1,254 | $9 |
| Ciprofloxacin | 132 | $1,025 | $8 |
| Nitrofurantoin | 33 | $893 | $27 |
| Doxazosin Mesylate | 37 | $888 | $24 |
| Sulfamethoxazole-Trimethoprim | 61 | $564 | $9 |
| Alfuzosin Hcl Er | 20 | $468 | $23 |
| Hydrocodone-Acetaminophen | 52 | $410 | $8 |
| Levofloxacin | 32 | $391 | $12 |
| Terazosin | 20 | $359 | $18 |
| Bicalutamide | 13 | $237 | $18 |
| Oxycodone-Acetaminophen | 11 | $109 | $10 |
2015: 30 drugs
| Xtandi | 11 | $101,994 | $9,272 |
| Vesicare | 164 | $54,474 | $332 |
| Tamsulosin | 1,156 | $37,164 | $32 |
| Toviaz | 130 | $32,593 | $251 |
| Myrbetriq | 131 | $30,944 | $236 |
| Rapaflo | 58 | $19,231 | $332 |
| Androgel | 41 | $19,046 | $465 |
| Finasteride | 1,059 | $14,721 | $14 |
| Avodart | 51 | $14,124 | $277 |
| Oxybutynin Chloride Er | 226 | $14,074 | $62 |
| Cialis | 32 | $7,129 | $223 |
| Potassium Citrate Er | 41 | $6,426 | $157 |
| Nitrofurantoin Mono-Macro | 100 | $5,744 | $57 |
| Enablex | 18 | $4,784 | $266 |
| Tolterodine Tartrate Er | 18 | $4,715 | $262 |
| Methenamine Hippurate | 41 | $4,514 | $110 |
| Nystatin-Triamcinolone | 19 | $2,050 | $108 |
| Jalyn | 12 | $1,957 | $163 |
| Oxybutynin Chloride | 32 | $986 | $31 |
| Ciprofloxacin | 159 | $905 | $6 |
| Bicalutamide | 25 | $778 | $31 |
| Amoxicillin-Clavulanate Potass | 24 | $745 | $31 |
| Cephalexin | 89 | $701 | $8 |
| Doxazosin Mesylate | 22 | $651 | $30 |
| Cefuroxime | 14 | $534 | $38 |
| Alfuzosin Hcl Er | 26 | $515 | $20 |
| Sulfamethoxazole-Trimethoprim | 67 | $404 | $6 |
| Levofloxacin | 27 | $256 | $9 |
| Hydrocodone-Acetaminophen | 37 | $248 | $7 |
| Terazosin | 13 | $238 | $18 |
2014: 32 drugs
| Vesicare | 98 | $30,016 | $306 |
| Toviaz | 95 | $20,765 | $219 |
| Myrbetriq | 87 | $16,641 | $191 |
| Avodart | 68 | $16,121 | $237 |
| Tamsulosin | 807 | $15,327 | $19 |
| Finasteride | 820 | $15,125 | $18 |
| Rapaflo | 66 | $13,797 | $209 |
| Oxybutynin Chloride Er | 92 | $6,213 | $68 |
| Nitrofurantoin Mono-Macro | 81 | $5,569 | $69 |
| Enablex | 22 | $4,590 | $209 |
| Advair Diskus | 12 | $3,668 | $306 |
| Potassium Citrate Er | 25 | $3,449 | $138 |
| Methenamine Hippurate | 33 | $2,891 | $88 |
| Cialis | 12 | $2,105 | $175 |
| Jalyn | 12 | $1,752 | $146 |
| Nystatin-Triamcinolone | 13 | $1,507 | $116 |
| Nitrofurantoin | 27 | $1,462 | $54 |
| Amox Tr-Potassium Clavulanate | 22 | $1,113 | $51 |
| Ciprofloxacin | 96 | $578 | $6 |
| Oxybutynin Chloride | 34 | $544 | $16 |
| Doxazosin Mesylate | 22 | $523 | $24 |
| Cephalexin | 59 | $410 | $7 |
| Bicalutamide | 12 | $371 | $31 |
| Levofloxacin | 31 | $367 | $12 |
| Sulfamethoxazole-Trimethoprim | 44 | $272 | $6 |
| Alfuzosin Hcl Er | 11 | $254 | $23 |
| Terazosin | 15 | $238 | $16 |
| Hydrocodone-Acetaminophen | 35 | $206 | $6 |
| Trimethoprim | 17 | $183 | $11 |
| Omeprazole | 12 | $137 | $11 |
| Timolol Maleate | 11 | $123 | $11 |
| Furosemide | 11 | $69 | $6 |
2013: 30 drugs
| Vesicare | 92 | $24,280 | $264 |
| Toviaz | 91 | $18,634 | $205 |
| Finasteride | 609 | $14,455 | $24 |
| Avodart | 69 | $13,977 | $203 |
| Rapaflo | 57 | $11,845 | $208 |
| Tamsulosin | 455 | $8,494 | $19 |
| Enablex | 44 | $7,797 | $177 |
| Nitrofurantoin Mono-Macro | 95 | $6,547 | $69 |
| Detrol La | 23 | $6,037 | $262 |
| Myrbetriq | 16 | $3,713 | $232 |
| Nystatin-Triamcinolone | 26 | $3,279 | $126 |
| Oxybutynin Chloride Er | 42 | $3,195 | $76 |
| Advair Diskus | 11 | $3,115 | $283 |
| Amox Tr-Potassium Clavulanate | 32 | $2,641 | $83 |
| Estrace | 13 | $1,815 | $140 |
| Jalyn | 12 | $1,600 | $133 |
| Nitrofurantoin | 30 | $1,311 | $44 |
| Betimol | 12 | $901 | $75 |
| Bicalutamide | 24 | $669 | $28 |
| Oxybutynin Chloride | 38 | $528 | $14 |
| Ciprofloxacin | 73 | $477 | $7 |
| Trimethoprim | 15 | $262 | $17 |
| Doxazosin Mesylate | 17 | $178 | $10 |
| Cephalexin | 24 | $167 | $7 |
| Terazosin | 17 | $157 | $9 |
| Levofloxacin | 21 | $150 | $7 |
| Omeprazole | 11 | $147 | $13 |
| Hydrocodone-Acetaminophen | 36 | $122 | $3 |
| Amlodipine Besylate | 11 | $97 | $9 |
| Furosemide | 11 | $76 | $7 |
Money from drug and device companies
$191 in 2025
| 2025 | 1 | 3 | None | $191 |
| 2024 | 2 | 3 | None | $61 |
| 2022 | 2 | 3 | None | $110 |
| 2020 | 1 | 2 | None | $63 |
| 2019 | 1 | 5 | None | $155 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Procept Biorobotics | Aquabeam Robotic System | $191 | 3 payments
|
See all 3 published payments
| Procept Biorobotics | Meals · 2025-05-03 | Aquabeam Robotic System | $19 |
| Procept Biorobotics | Meals · 2025-05-03 | Aquabeam Robotic System | $26 |
| Procept Biorobotics | Meals · 2025-05-02 | Aquabeam Robotic System | $146 |
See earlier years (2024, 2022, 2020, 2019)
2024: $61
| Endo USA | Xiaflex | $41 | 2 payments
|
| Olympus America | Soltive | $19 | 1 payment
|
2022: $110
| Boston Scientific | General - Therapies | $72 | 2 payments
|
| Dornier MedTech America | Dornier Medtech | $38 | 1 payment
|
2020: $63
| NeoTract | Urolift | $63 | 2 payments
|
2019: $155
| NeoTract | Urolift | $155 | 5 payments
|
Professional record
- NPI
- 1851447965
- Licence
- CA A84986California A84986: Current · expires 2027-08-31
- Trained
- University of California, Irvine, California College of Medicine, 2002
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA ZZZ83789Z
- Taxonomy
- Urology (208800000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-01-25
- NPI last updated
- 2020-06-22
- NPI record certified
- 2020-06-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1828 El Camino Real, Burlingame, CA, 94010